Integrating Buprenorphine Into the SFGH AIDS Program (BHIVES-SF)
HIV, Buprenorphine, Opioid Dependence
About this trial
This is an interventional treatment trial for HIV focused on measuring HIV, acquired immunodeficiency syndrome, buprenorphine, opioid dependence, opioid-related disorders, integrated care, primary care
Eligibility Criteria
Inclusion Criteria: Age > 18 years Fluent in English Receive HIV primary care at the UCSF Positive Health Program Meet DSM-IVR criteria for opioid dependence Meet clinical criteria for buprenorphine treatment (see Exclusion Criteria) Plan to stay in the San Francisco Bay Area for the next 12 months Exclusion Criteria: Severe hepatic dysfunction, i.e., AST and/or ALT > 5X upper limit of normal DSM-IV criteria for benzodiazepine abuse or dependence within the past 6 months DSM-IV criteria for alcohol dependence within the past 6 months Actively suicidal Psychiatric impairment that impedes ability to consent (dementia, delusional, actively psychotic) Methadone or opiate analgesic doses exceed level allowing for safe transition to buprenorphine Pregnant women and women actively trying to become pregnant Potential subjects also will be excluded for: Any medical condition(s), which, in the opinion of the investigator, would interfere with the patient's ability to participate in or adhere to the requirements of this study Unable or who decline to provide informed consent for the evaluation
Sites / Locations
- UCSF Positive Health Program
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Integrated
Non-integrated
Buprenorphine maintenance treatment delivered at an HIV primary care clinic
Buprenorphine maintenance treatment delivered at a public health substance use disorder clinic